packageMeglumineAntimonate

meglumine antimonate

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Meglumine antimonate is an antiprotozoal medicine used to treat leishmaniasis. It is listed as an essential medicine by the WHO, but in some databases it is classified as investigational rather than an approved drug.

Summary written by glm-5.3-flash from Wikidata Q2757969 and the WHO ATC classification; not checked by a person.

name:meglumine antimonate
ATC codes:P01CB01
DrugBank:DB13732
PubChem CID:64953
Wikidata:Q2757969
formula:C7H18NO8Sb
molar mass:365.98 g/mol (PubChem CID 64953)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown